Latest Insider Transactions at Black Diamond Therapeutics, Inc. (BDTX)
This section provides a real-time view of insider transactions for Black Diamond Therapeutics, Inc. (BDTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Black Diamond Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Black Diamond Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 14
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
642
-0.06%
|
$21,186
$33.09 P/Share
|
|
Oct 14
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
5,501
-0.07%
|
$181,533
$33.09 P/Share
|
|
Oct 13
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
10,370
-0.18%
|
$342,210
$33.39 P/Share
|
|
Oct 13
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
1,369
-0.14%
|
$45,177
$33.39 P/Share
|
|
Oct 13
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
11,739
-0.16%
|
$387,387
$33.39 P/Share
|
|
Oct 12
2020
|
Brent Hatzis Schoch |
SELL
Open market or private sale
|
Direct |
4,078
-31.2%
|
$134,574
$33.18 P/Share
|
|
Oct 12
2020
|
Brent Hatzis Schoch |
BUY
Exercise of conversion of derivative security
|
Direct |
4,078
+36.55%
|
$12,234
$3.2 P/Share
|
|
Oct 12
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
353
-0.01%
|
$11,649
$33.11 P/Share
|
|
Oct 12
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
47
-0.0%
|
$1,551
$33.11 P/Share
|
|
Oct 12
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
400
-0.01%
|
$13,200
$33.11 P/Share
|
|
Oct 09
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
3,357
-0.06%
|
$110,781
$33.67 P/Share
|
|
Oct 09
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
443
-0.04%
|
$14,619
$33.67 P/Share
|
|
Oct 09
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
3,800
-0.05%
|
$125,400
$33.67 P/Share
|
|
Oct 08
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
16,276
-0.14%
|
$537,108
$33.47 P/Share
|
|
Oct 08
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
2,149
-0.11%
|
$70,917
$33.47 P/Share
|
|
Oct 08
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
18,425
-0.12%
|
$608,025
$33.47 P/Share
|
|
Oct 08
2020
|
Thomas Leggett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-100.0%
|
$99,000
$33.53 P/Share
|
|
Oct 08
2020
|
Thomas Leggett Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$30,000
$10.86 P/Share
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Other acquisition or disposition
|
Indirect |
294,920
-54.15%
|
-
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
5,312
+48.21%
|
-
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
24,590
-0.43%
|
$811,470
$33.56 P/Share
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
3,246
-0.31%
|
$107,118
$33.56 P/Share
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
1,471
+6.36%
|
-
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
294,920
-54.15%
|
-
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
5,312
+48.21%
|
-
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
27,836
-0.37%
|
$918,588
$33.56 P/Share
|
|
Oct 06
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
15,980
-0.28%
|
$527,340
$33.26 P/Share
|
|
Oct 06
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
2,110
-0.2%
|
$69,630
$33.26 P/Share
|
|
Oct 06
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
18,090
-0.24%
|
$596,970
$33.26 P/Share
|
|
Oct 05
2020
|
Christopher D. Roberts Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,500
-95.46%
|
$77,500
$31.59 P/Share
|
|
Oct 05
2020
|
Christopher D. Roberts Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$25,000
$10.86 P/Share
|
|
Oct 01
2020
|
David M. Epstein |
SELL
Open market or private sale
|
Direct |
12,000
-1.64%
|
$360,000
$30.33 P/Share
|
|
Oct 01
2020
|
David M. Epstein |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.41%
|
$18,000
$6.42 P/Share
|
|
Sep 30
2020
|
Robert Alexander Ingram |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$150,000
$30.46 P/Share
|
|
Feb 03
2020
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400,000
+33.93%
|
$7,600,000
$19.0 P/Share
|
|
Feb 03
2020
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
378,790
+50.0%
|
-
|